Member Info for Porky9

Don’t deflect Riddler, B@llox to what GDR do, that’s their business how that’s run, likewise your beloved PYC and likewise what APTA do: although I was impressed that the earlier takeover ramp post was doing a two for one to include APTA and VAL in the same deal, perhaps they should have thrown PYC in the mix as well. All three need a ramp.

But the forum here is for this penny share play and nothing else, so let’s keep the debate on point shall we???

Question for Monday is How much/ Will it secure support/ what is the chance of an ROI following the mass dilution if he gets it over the line?

No sweating, no anything, I’m calling the BS posted here out for what it is. Just amazed some of the old crew posting yet again for anything other than a Ramp attempt. What next, a return of JWallows?

Some secret stateside fund of £67million pounds ready to deploy? Oh please, I guess you can fool some of the people some of the time.

And Riddler, get your facts right Suzy Dilly salary package and benefits in 2023 year were £162,585 and in 2022 the year before that £163,469 it’s specified in the annual report. Your call if you think that was money well spent or not?

Depends what you are actually doing for your salary Riddler

If it’s attending 12 zoom meeting a year for your BOD salary then no, i would consider it’s poor value return for investors

If it’s being employed as a BDM with a mandate to win new business and you secure FA in business sales in the best part of 15 years, let alone 3 months which is a typical sales manager target period, then again I would say that is also poor value investors cash spent.

If it’s Lab salaries but none of the work results in paid invoices then there is an argument to say we could be paying for busy fools?

Harsh, probably BUT my point is that ME has to make a pound go a long way, wasting cash jet setting to the states to play golf whilst attending trade fairs, still squandering cash on a PR firm, keeping effectively friends employed rather than looking at what is viable for the business and most importantly not demonstrating the commercial acumen required to date to turn this around is not great value - sorry

Let’s see the presentation Monday, but I will call time on outrageous pumps here in this forum if only so that small SH don’t get sucked in to be shafted yet again through these forum antics.

When the P&D starts, if you are trapped here, get out on it before they sell it under you because that is what is about to happen.

Either that or the placing doesn’t get supported and it goes into administration

Unbelievable

Newbies or multi account posters joining the forum in an attempt to pump this - disgusting, the FCA should be on this forum like a rash - how many times now?

It’s a total disgrace frankly

Absolute total 100% BS but I compliment you on trying to start a desperate last moment ramp to get this stock pumped to enable potential placing supporters to sell into it.

The Intangible asset values on the field accounts are £718k and an administrator would likely write those values down significantly lower.

I can tell you now that in Administration you would be able to pick up the entire asset base here, or rather the bits you want, if any, in the region of about £60k to £80k absolute top side.

The staffing liabilities alone don’t make it viable.

So your dreams that under due diligence some company is going to bid an eye watering amount is not just silly and ridiculous, it’s utterly preposterous and I call it out for what it is - a shameless ramp.

I’m expecting t9 see more of this kind of BS in the coming days as every trick in the book is tried to get investors to part with their hard earned cash

@Uncanny

Oh I like it, a sort of a “we still believe 201 will be executed, they are raising funds” RNS and then “ we need you to tip up £2m but I will contribute 10% myself (draw it back in salary) in the meantime whilst events take place”

Sounds like a plan, needs to do something ideally to pump the SP to be sold into that’s for sure. But will punters buy into that yet again,? Are investors that stupid? Maybe some are

Vegas casino - that’s quite funny for you Riddler, you need a sense of humour to pump this one and PYC 24/7 x brilliant

100m good grief, it’s worth less than 100k from administrators - there is nothing here left of any value. Suzy and Kevin killed it off. ME is now looking to effectively start again.

But keep pumping it, God loves a trier.

Why does it effect you what International work I do at different hours? Who cares I can comment when I like from wherever I like.

Rather than insult/ discredit how about you tell me why this is worth chucking more money at the discounted placement to keep all the deadwood employed as before?

You won’t be able to say but we should hear from the horses mouth on Monday

201 is DEAD, Dead totally DEAD, more dead than the Norwegian blue parrot!

Look, if by some remote possibility THX got funds together, not likely after all this time, 201 would needs loads of time and money spent on it to bring it up to date, reformulate it, new patents, peer reviews the lot before phase trials could even be started. It’s years off, if ever as I consider it’s most likely now superseded. It’s over 15 yrs old now, hence why I say it’s dead.

Due to the massive costs involved with phased trials Anyone wanting to take 201 on now would owe it their shareholders to renegotiate the terms anyhow, on a milestone only basis no upfront cash. But let’s say, totally unlikely, someone now executed that same LOI dead from back in 2021 and chucked the £1.2m cash upfront at them, all it does is pay to keep BOD lifestyles going for another 6 months.

But keep the insults coming rampers, I don’t care, it is what it is. He will need a good fantasy Hope story to try and pump the SP so it can be sold into to get a placing away. There is no buy volume so a good twitter pump story would help. Where is JWallows when you need him.

Rinse, repeat, raise, spend, raise, spend, consolidate.

I see the usual rampers back out as a tag team again looking to insult or discredit posters rather than address the issues here.

Let’s see what the proposed placing looks like Monday.

His cash burn sits at £2.3m for the year, that doesn't account for any Suzy payoff post results and the admin costs are obscene for what really is now an effective start up - rebuilding from scratch again.

He has to offer a cost reduction for sure, just offloading one NED wont cut it, Cash burn needs to be back under £1.4m again. I don't see 201 being sold in the next couple of years, the tech is so dated now and needs time and money spent on it to reformulate and obtain new patents on it - the question is as its over 15 years old now, has it been superseded by something else in that time, it never completed that peer review. Feels like ME is just holding on to it thinking "hope" is a better position for placing investors than sorting the issue/ killing it off it not viable.

BUT to rebuild that pipeline now from scratch again would increase cash burn so this probably needs in the region of two further raises of £2.5m a go IMO based on where it is today starting again.

CLX I think has legs, but is it enough on its own? its a good couple of years away. The damage done was allowing them to chase this ridiculous biobank building concept at the detriment of adding new evaluations hence why we have no pipeline - all needs rebuilding again as momentum totally lost.

If I'm totally honest previously my intention was when Adrian first brought the motion of change forward (Shame AH didn't call it a year earlier) i thought if they get a grip of this. clear the dead wood, get 8-9 new evaluations scheduled I would give it a go and back a discounted placing but unfortunately, they have just ignored it and let it drift and drift, even now today, they are still holding out for THX and 201 - i mean please come on....Jesus its more dead than the Norwegian blue parrot if that's possible?

Look, if he gets this placing away, even chucks £200k in himself (even if its draw back out in salary and benefits) I’m struggling to see where investor return would come? but good luck to him if he can do it.

As I say, its an impossible situation he has inherited, if I was ME if I’m totally honest I would let it collapse into admin and offer £100k to liquidators to acquire the CLX rights and maybe any other bits worth having and reverse them into his ONCOLYTIKA LTD business for long burn, contact a few possible partners himself should he ever get a deal in the future.

That's how I see it. If he does get the placing across the line, I doff my hat to him but in this climate now, I don’t see the appetite but maybe I will be surprised.

Pork's

Some decent blocks being purchased 500,000 a time, very interesting.

Should do, we touched 4.5 a few weeks back and there are potential massive deals now on the horizon.

Nice to see steady buys and sells into them all day, bodes well

I specifically like the fact that the CEO has significant skin in the game at 3.1p, he wouldn't be increasing his holding exposure if he didn't have confidence in the business.

Further he has positioned two other businesses in the 200-250m valuation range and so lets hope he can deliver the same here.

I think the outcome of the two NHS evaluations end of this month and any stateside breakthroughs will be the making of this penny play. Time will tell i guess.

@PM2022 is just attempting to troll me specifically. Thanks @PM2022 if your posts help put buyers off, was able to add a few more this low, there will be a material move here shortly. Good luck.

Haven’t got any questions, ME covered everything at the pitching event and the slides are online.

It’s down to you if you want to dig deep and support again or not

As @Lionel1 reminds us, first acid test will be if any success with the two NHS assesments outcome end of this month:-

We have basically 2 assessments in progress and both are expected on 31st October 2024.

https://shtg.scot/our-advice/genotype-testing-to-guide-antibiotic-use-and-prevent-hearing-loss-in-babies/

https://shtg.scot/our-advice/clopidogrel-genotype-testing-after-ischaemic-stroke-or-transient-ischaemic-attack-tia/

Will see

@PM2022 and @Laura2022 (aka Riddler)

You can troll me as much as you like, if it gives you pleasure crack on with it. Meanwhile, let’s see how your VAL investment works out for you. Have fun.

IF and it’s a big IF, some decent sized contracts land either NHS under the current evaluation or stateside and by decent I mean, U.K. roll out, combination of orders stateside or deals in the region of £20m then there is no reason why the SP couldn’t rally towards 50p.

No many plays with a 20 bag upside potential from here that’s for sure, could it do it? Possibly, but in the meantime it could well get some of the way and let’s not forget do a lot of good for a lot of adult stroke sufferers not to mention hearing loss risk reduction in babies which is every parents nightmare in that situation.

On balance, I wouldn’t bet the house but worth squirrelling a few away, will know soon enough, stage 1 end of this month’s first NHS evaluation. At least something short term to aim for which is always a bonus to maintain interest in these markets.

Good luck